Calvert Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-17,431
Closed -$1.14M 417
2016
Q4
$1.14M Sell
17,431
-4,886
-22% -$317K 0.04% 363
2016
Q3
$1.58M Sell
22,317
-12,529
-36% -$913K 0.06% 320
2016
Q2
$2.58M Sell
34,846
-80,782
-70% -$5.58M 0.1% 218
2016
Q1
$7.5M Sell
115,628
-38,738
-25% -$2.64M 0.33% 78
2015
Q4
$11.9M Buy
154,366
+37,882
+33% +$3.01M 0.54% 46
2015
Q3
$9.59M Sell
116,484
-4,721
-4% -$420K 0.48% 51
2015
Q2
$10.7M Buy
121,205
+69,307
+134% +$6.36M 0.47% 59
2015
Q1
$4.59M Buy
51,898
+5,356
+12% +$475K 0.3% 99
2014
Q4
$3.86M Buy
46,542
+1,207
+3% +$100K 0.26% 104
2014
Q3
$3.82M Sell
45,335
-6,440
-12% -$521K 0.28% 104
2014
Q2
$4.2M Buy
51,775
+1,536
+3% +$121K 0.28% 100
2014
Q1
$3.83M Buy
50,239
+14,646
+41% +$1.07M 0.27% 100
2013
Q4
$2.56M Buy
35,593
+22,698
+176% +$1.58M 0.19% 110
2013
Q3
$886K Hold
12,895
0.11% 163
2013
Q2
$817K Buy
+12,895
New +$839K 0.11% 159

Other funds holding NVS

Calvert Investment Management's NVS Position: Q1 2017 in Review

Calvert Investment Management sold out of Novartis (NVS) in Q1 2017, closing a stake of 17,431 shares — an estimated $1.14M sold.

Calvert Investment Management first reported a position in NVS in Q2 2013 and held it in 15 quarters. The position peaked at $11.9M in Q4 2015. 909 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

  • Calvert Investment Management reported no remaining Novartis position as of Q1 2017 after selling out during the quarter.
  • Calvert Investment Management sold 17,431 Novartis shares in Q1 2017, an estimated $1.14M.
  • Calvert Investment Management first reported a position in Novartis in Q2 2013 and held it in 15 quarters.
  • Calvert Investment Management's Novartis position peaked at $11.9M in Q4 2015.
  • 909 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.